Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Location


Corporate Headquarters

Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States

Telephone Numbers



Customer Service: (800) 227-6666 / (650) 697-3600


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-B8916-50 50 µl (1 mg/ml) $460 
RXFP2 / LGR8 Antibody - Anti-RXFP2 / LGR8 antibody IHC staining of human breast. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.

IHC‑plus™ Polyclonal Rabbit anti‑Human RXFP2 / LGR8 Antibody (C‑Terminus, IHC) LS‑B8916

IHC‑plus™ Polyclonal Rabbit anti‑Human RXFP2 / LGR8 Antibody (C‑Terminus, IHC) LS‑B8916

Note: This antibody replaces LS-C155077
Antibody:
RXFP2 / LGR8 Rabbit anti-Human Polyclonal (C-Terminus) Antibody
Application:
IHC, IHC-P, ELISA
Reactivity:
Human, Monkey
Format:
Unconjugated, Unmodified
Price
Catalog Number
$460
LS-B8916-50
Toll Free North America
(800) 227-6666
For Research Use Only

Overview

Antibody:
RXFP2 / LGR8 Rabbit anti-Human Polyclonal (C-Terminus) Antibody
Application:
IHC, IHC-P, ELISA
Reactivity:
Human, Monkey
Format:
Unconjugated, Unmodified

Specifications

Description
LGR8 antibody LS-B8916 is an unconjugated rabbit polyclonal antibody to LGR8 (RXFP2) (C-Terminus) from human. It is reactive with human and monkey. Validated for ELISA and IHC. Tested on 20 paraffin-embedded human tissues.
Target
Human RXFP2 / LGR8
Synonyms
RXFP2 | G-protein coupled receptor 106 | GPR106 | INSL3R | LGR8 | GREAT | Relaxin receptor 2 | LGR8.1 | RXFPR2
Host
Rabbit
Reactivity
Human, Monkey (tested or 100% immunogen sequence identity)
Clonality
IgG Polyclonal
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Modifications
Unmodified
Immunogen
Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human Relaxin Receptor 2. The exact sequence is proprietary.
Epitope
C-Terminus
Specificity
Human RXFP2
Applications
  • IHC
  • IHC - Paraffin (10 µg/ml)
  • ELISA
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
Usage
Antibody reactive against peptide, detects immunogen.
Presentation
0.1 M Tris, pH 7, 0.1 M Glycine, 10% Glycerol, 0.01% Thimerosal
Storage
Aliquot and freeze at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About RXFP2 / LGR8
Q8WXD0 NM_130806 NP_570718.1

Validation

RXFP2 / LGR8 Antibody - Anti-RXFP2 / LGR8 antibody IHC staining of human breast. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.
Anti-RXFP2 / LGR8 antibody IHC staining of human breast. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.
Anti-RXFP2 / LGR8 antibody IHC staining of human breast. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.

LSBio Ratings

IHC-plus™ RXFP2 / LGR8 Antibody (C-Terminus) for IHC, ELISA LS-B8916 has an LSBio Rating of
Laboratory Validation Score (4)

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 11/22/2024